ESTIV Congress 2026 > Programme

Programme

Congress theme: Ensuring Safety, Advancing Science: Bridging to the Future with NAMs

The ESTIV 2026 Congress focuses on the dual responsibility of ensuring human and environmental safety while advancing scientific innovation, highlighting New Approach Methodologies (NAMs) as a key bridge between cutting-edge research and real-world application. As toxicology moves toward more human-relevant, mechanistic, and data-driven approaches, NAMs offer unprecedented opportunities to improve predictive power, efficiency, and ethical standards.


Final Programme

The programme is still subject to changes

Monday, June 29th, 2026

9:00-13:00 Pre-Congress workshop I
Room 0.8
Research output management for NAMs made easy

9:00-13:00 Pre-Congress workshop II
Room 0.4
Episkin Academy Training

14:00-14:15: Opening Ceremony of the ESTIV 2026 Congress
Auditorium 2
Chairs: Dr Helena Kandarova (CEM SAS, Bratislava, Slovakia) & Dr Clive Roper (Roper Toxicology Consulting Limited, Edinburgh, UK)

Opening ceremony act by FlowMies

Michelle Verhoeks, also known as FlowMies, is a Dutch flow artist from Eindhoven who has gained international recognition for her powerful hoop dance and flow art performances. Using hoops as her dance partners, she combines movement, light, and fire to create a truly memorable spectacle.
FlowMies blends dynamic live performances with elements of dance, visual art, and storytelling, resulting in an immersive and captivating show experience. Her performances have been featured in theatres and festivals, as well as on four episodes of Holland’s Got Talent in 2024, where she reached the Top 3 in the grand finale.

14:15-15:00: Keynote lecture I Dr. Katrin Schutte – EC roadmap towards phasing out animal testing for chemical safety assessments (Auditorium 2)
15:00-15:30: BEMA 2026 award and lecture (Auditorium 2)
15:30 – 16:00: ESTIV 2026 Early Scientific Career Award and Lecture (Auditorium 2)

16:00-16:30: Coffee break, visiting exhibition area & poster viewing (Expo Foyer)

16:30-18:30: Session 1 –🟦We know many of the barriers to adoption of NAMs, but what are the solutions? (Auditorium 2)

18:30-20:00: Welcome reception & poster session (Expo Foyer)


Tuesday, June 30th, 2026
Theme: Regulatory Foundations & Standards

08:30-09:00 Keynote Lecture II – Kelly Coleman – NAMs and Medical Devices: Challenges & Successes (Auditorium 2)

09:00-10:30: Session 2 – 🟦 Track A: Update to OECD guidance document 34 on validation of methods & defined approaches (Auditorium 2)

09:00-10:30: Session 2 – 🟩 Track B: VHP4Safety β€” Next generation safety based on human data (Room 0.4/0.5)


10:30-11:00: Coffee break, visiting exhibition area & poster viewing (Expo Foyer)


11:00-13:00: Session 3 – 🟦 Track A: International standards as the bridge to the future of safe medical devices (Auditorium 2)

11:00-13:00: Session 3 – 🟩 Track B: Development and regulatory acceptance of NAMs in genetic toxicology (Room 0.4/0.5)


13:00-14:00: Lunch break, visiting exhibition area & poster viewing (Expo Foyer)


14:00 – 14:30 – Announcement of Liebsch & Spielman Award (Auditorium 2)



16:00-16:30: Coffee break, visiting exhibition area & poster viewing (Expo Foyer)


16:30-17:30: Early Stage Researcher Session 1 (Auditorium 2)

16:30-18:30: Session 5 – 🟩 Track B: From research to regulation: standardising innovative non-animal technologies (Room 0.4/0.5)


18:3019:30: ESTIV General assembly (Room 0.4/0.5)

18:30 – 19:30: Poster Session (Expo Foyer)


Wednesday, July 1st, 2026
Theme: Applications and collaboration β€” Food, Environment & Therapeutics

08:30-09:00 Keynote Lecture IIIProf. Liesbet Geris – Virtual Human Twins for advancing personalised toxicology (Auditorium 2)

09:00-10:30: Session 6 – 🟦 Track A: Advancing the use of NAMs in food safety (Auditorium 2)

09:00-10:30: Session 6 – 🟩 Track B: Replacing animals in therapeutic monoclonal antibody approvals (Room 0.4/0.5)


10:30-11:00: Coffee break, visiting exhibition area & poster viewing (Expo Foyer)


11:00-13:00: Session 7 – 🟦 Track A: Complex chemical mixtures across environment-food-human continuum (Auditorium 2)

11:00-13:00 Session 7 – 🟩 Track B: Beyond positive results β€” interpreting NAMs for endocrine disruptors (Room 0.4/0.5)


13:00-14:00: Lunch break, visiting exhibition area & poster viewing (Expo Foyer)

13:00-14:00: Lunch session – Building Regulatory Confidence with Immune Competent MPS for Toxicity Assessments (Room 0.4/0.5)

Session organised by:


14:00-15:30 Session 8 – 🟦 Track A: Systemic effects evaluation using NAM toolboxes – real-world cases (Auditorium 2)

14:00-15:30 Session 8 – 🟩 Track B: Towards robust and reliable in vitro models for developmental and reproductive toxicology (Room 0.4/0.5)



16:30-17:00: Coffee break, visiting exhibition area & poster viewing (Expo Foyer)


17:00-18:30:  – Session 9 – 🟦 Track A: Multimodal modelling
of the gut compartment – NAMs for food safety
(Auditorium 2)

17:00-18:30:  Session 9 🟩 Track B: NAMs in cardiac safety (Room 0.4/0.5)

18:30 – 19:30 – Early Stage Researcher session 2 (Auditorium 2)

18:30 – 19:30: Session 10 – 🟩 Track B:State of the art in in vitro DART assays β€” the bigger picture (Room 0.4/0.5)



19:30 – Departures to congress dinner & social evening


Thursday, July 2nd, 2026
Theme: Advanced Methods, AI, Inhalation Toxicology

08:30 – 9:00 Keynote lecture IVProf. Jinhee Choi – Beyond the black box: bridging human and environmental safety via AOP-Based explainable AI for NGRA (Auditorium 2)

09:00-11:00: Session 11 – 🟦 Track A: Advances & challenges in high throughput transcriptomics for risk assessment (Auditorium 2)

09:00-11:00: Session 11 – 🟩 Track B: Guidance for in vitro Air–Liquid interface inhalation toxicity assessment (Room 0.4/0.5)


11:00-11:30: Coffee break (Trajectum/Lobby)


11:30-12:45: Session 12 – 🟦 Track A: AI-Powered toxicity screening β€” 3Rs and regulatory adoption (Auditorium 2)

11:30 – 12:45: Session 12 πŸŸ© Track B:application & standardisation of in vitro inhalation methods (Room 0.4/0.5)

12:45-13:30: Congress closing ceremony

(Auditorium 2)
Chairs: Dr Helena Kandarova (CEM SAS, Bratislava, Slovakia) & Dr Clive Roper (Roper Toxicology Consulting Limited, Edinburgh, UK)


POST-CONFERENCE ACTIVITIES


Friday, July 3rd, 2026

09:00 ASPIS open symposium and ASPIS ACADEMY session on GIVIMP

Registration for this event is managed via the ASPIS Open Symposium 2026 registration module. Participation is free and open on a first come, first served basis, with a maximum capacity of 150 participants or until 1 June 2026.
Please click the link above to access the registration form.